Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · IEX Real-Time Price · USD
11.00
0.00 (0.00%)
Jul 22, 2024, 10:11 AM EDT - Market open

Roivant Sciences Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Year Ending
CurrentMar 31, 2024Mar 31, 2023Mar 31, 2022Mar 31, 2021Mar 31, 2020
Market Capitalization
8,1928,4945,5973,419502-
Market Cap Growth
51.75%51.75%63.72%580.90%--
Enterprise Value
2,0902,4584,4021,642-1,386-2,005
PE Ratio
2.101.95-5.55-4.04-0.62-
PS Ratio
65.1168.0691.3461.8421.10-
PB Ratio
1.361.424.832.060.28-
P/FCF Ratio
-11.08-11.08-6.54-4.92-0.90-
P/OCF Ratio
-11.10-11.10-6.64-5.04-0.91-
EV/Sales Ratio
16.7519.6971.8329.71-58.23-29.61
EV/EBITDA Ratio
0.470.55-4.64-1.991.72-1.66
EV/EBIT Ratio
0.470.56-4.51-1.961.72-1.66
EV/FCF Ratio
-3.21-3.21-5.14-2.362.482.62
Debt / Equity Ratio
0.080.080.420.170.140.09
Debt / EBITDA Ratio
0.110.11-0.51-0.34-0.300.15
Debt / FCF Ratio
-0.65-0.65-0.56-0.41-0.44-0.24
Quick Ratio
24.5024.506.1511.189.7423.72
Current Ratio
25.2425.246.6011.649.9924.09
Asset Turnover
0.030.030.030.020.01-
Interest Coverage
126.69126.69-34.89-119.00--
Return on Equity (ROE)
125.00%125.00%-86.60%-46.40%-42.30%-
Return on Assets (ROA)
92.80%92.80%-42.90%-30.90%-31.90%-
Return on Capital (ROIC)
65.25%65.25%-71.70%-69.64%-52.42%-23.92%
Earnings Yield
53.52%51.20%-18.03%-24.72%-161.17%-
FCF Yield
-9.43%-9.03%-15.29%-20.33%-111.12%-
Buyback Yield / Dilution
-16.59%-16.59%-6.43%-6.30%-187.64%-
Total Shareholder Return
-16.59%-16.59%-6.43%-6.30%-187.64%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).